REGISTERED NUMBER: 15556809 (England and Wales)

OJAS IMMUNE LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2026

Page

Balance Sheet

1

Chartered Accountants' Report

3

FIXED ASSETS

6,637

-

CURRENT ASSETS

209,451

2,276

CREDITORS

Amounts falling due within one year

(22,940

)

(13,750

)

NET CURRENT ASSETS/(LIABILITIES)

186,511

(11,474

)

TOTAL ASSETS LESS CURRENT LIABILITIES

193,148

(11,474

)

CAPITAL AND RESERVES

193,148

(11,474

)

NOTES TO THE FINANCIAL STATEMENTS

1.	STATUTORY INFORMATION

Ojas Immune Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

15556809

Registered office:

6-7 Citibase, New Barclay House

234 Botley Road

Oxford

OX2 0HP

2.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 3 (2025 - NIL ) .

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 10 July 2026 and were signed on its behalf by:

Dr. A S Ramadass - Director

The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement is not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Ojas Immune Limited for the year ended 31 March 2026 which comprise the Income Statement, Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of Ojas Immune Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Ojas Immune Limited and state those matters that we have agreed to state to the Board of Directors of Ojas Immune Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Ojas Immune Limited and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that Ojas Immune Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of Ojas Immune Limited. You consider that Ojas Immune Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Ojas Immune Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Mercer Lewin Ltd

Chartered Accountants

6-7 Citibase

New Barclay House

234 Botley Road

Oxford

OX2 0HP

10 July 2026